Jeffrey V. Poulton - Insider Trading & Ownership

Location
300 Third Street, Cambridge, MA
Summary
The estimated net worth of Jeffrey V. Poulton is at least $25.5M dollars as of October 3, 2025. Jeffrey V. Poulton is the EVP, Chief Financial Officer of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $25.2M. Jeffrey V. Poulton is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $309K.
Signature
By: Brett Budzinski, Attorney-in-Fact For: Jeffrey V. Poulton
All Insider Reports
All Insider Reports

Ownership of Jeffrey V. Poulton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer $25.2M -$3.93M -13.5% Oct 1, 2025
QTTB Q32 Bio Inc. Director $309K Jun 14, 2023
CRVO CervoMed Inc. Director Jun 23, 2025

Insider Transactions Reported by Jeffrey V. Poulton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.